LakeShore Biopharma (LSB) Competitors $0.53 -0.26 (-32.95%) Closing price 09/19/2025Extended Trading$0.53 0.00 (0.00%) As of 09/19/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LSB vs. SNTI, XLO, DYAI, LVTX, GBIO, GRCE, MRSN, BTAI, ALVR, and JSPRShould you be buying LakeShore Biopharma stock or one of its competitors? The main competitors of LakeShore Biopharma include Senti Biosciences (SNTI), Xilio Therapeutics (XLO), Dyadic International (DYAI), LAVA Therapeutics (LVTX), Generation Bio (GBIO), Grace Therapeutics (GRCE), Mersana Therapeutics (MRSN), BioXcel Therapeutics (BTAI), AlloVir (ALVR), and Jasper Therapeutics (JSPR). These companies are all part of the "pharmaceutical products" industry. LakeShore Biopharma vs. Its Competitors Senti Biosciences Xilio Therapeutics Dyadic International LAVA Therapeutics Generation Bio Grace Therapeutics Mersana Therapeutics BioXcel Therapeutics AlloVir Jasper Therapeutics LakeShore Biopharma (NASDAQ:LSB) and Senti Biosciences (NASDAQ:SNTI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability. Do analysts prefer LSB or SNTI? Senti Biosciences has a consensus target price of $9.67, suggesting a potential upside of 355.55%. Given Senti Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Senti Biosciences is more favorable than LakeShore Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LakeShore Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Senti Biosciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, LSB or SNTI? LakeShore Biopharma has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Senti Biosciences has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Is LSB or SNTI more profitable? LakeShore Biopharma's return on equity of 0.00% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets LakeShore BiopharmaN/A N/A N/A Senti Biosciences N/A -223.98%-76.02% Does the media favor LSB or SNTI? In the previous week, Senti Biosciences had 12 more articles in the media than LakeShore Biopharma. MarketBeat recorded 13 mentions for Senti Biosciences and 1 mentions for LakeShore Biopharma. Senti Biosciences' average media sentiment score of 0.72 beat LakeShore Biopharma's score of 0.00 indicating that Senti Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LakeShore Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Senti Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, LSB or SNTI? LakeShore Biopharma has higher revenue and earnings than Senti Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeShore Biopharma$85.67M0.13-$13.93MN/AN/ASenti Biosciences$2.56M21.68-$52.79M-$8.95-0.24 Do insiders and institutionals have more ownership in LSB or SNTI? 52.6% of LakeShore Biopharma shares are held by institutional investors. Comparatively, 25.7% of Senti Biosciences shares are held by institutional investors. 3.1% of Senti Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummarySenti Biosciences beats LakeShore Biopharma on 8 of the 13 factors compared between the two stocks. Get LakeShore Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LSB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LSB vs. The Competition Export to ExcelMetricLakeShore BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.01M$3.41B$6.16B$10.54BDividend YieldN/A2.30%5.73%4.78%P/E RatioN/A23.0685.1227.35Price / Sales0.13436.89574.81179.28Price / CashN/A46.1137.3961.86Price / Book0.1610.5912.406.73Net Income-$13.93M-$52.47M$3.32B$276.90M7 Day PerformanceN/A0.14%707.07%-0.35%1 Month Performance-34.20%15.80%934.50%6.80%1 Year Performance-85.68%15.43%2,402.04%38.04% LakeShore Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LSBLakeShore BiopharmaN/A$0.53-33.0%N/A-86.0%$11.01M$85.67M0.00773News CoverageHigh Trading VolumeSNTISenti Biosciences2.7209 of 5 stars$1.73+3.6%$8.50+391.3%+13.5%$43.69M$2.56M-0.194Trending NewsAnalyst ForecastAnalyst RevisionXLOXilio Therapeutics2.005 of 5 stars$0.82-0.3%$3.00+264.8%-1.3%$42.74M$6.34M-1.0870DYAIDyadic International3.1286 of 5 stars$1.14-3.4%$6.00+426.3%-5.5%$42.70M$3.49M-6.007Gap UpLVTXLAVA Therapeutics1.8752 of 5 stars$1.62+0.6%$2.69+65.7%-5.3%$42.35M$11.98M-1.5460News CoverageInsider TradeGBIOGeneration Bio3.8119 of 5 stars$6.23-0.6%$10.67+71.2%-72.3%$42.23M$19.89M-0.58150GRCEGrace Therapeutics2.64 of 5 stars$3.02flat$12.00+297.4%N/A$41.76MN/A-3.51N/APositive NewsMRSNMersana Therapeutics4.2634 of 5 stars$7.96-2.9%$56.60+611.1%-80.2%$40.92M$40.50M-0.54150BTAIBioXcel Therapeutics4.2819 of 5 stars$2.50-2.0%$39.75+1,490.0%-70.6%$40.82M$2.27M-0.2090ALVRAlloVirN/A$8.03+20.9%N/A-71.7%$40.50MN/A-0.40110High Trading VolumeJSPRJasper Therapeutics3.4252 of 5 stars$2.43+1.3%$25.63+954.5%-85.8%$39.01MN/A-0.4020 Related Companies and Tools Related Companies Senti Biosciences Competitors Xilio Therapeutics Competitors Dyadic International Competitors LAVA Therapeutics Competitors Generation Bio Competitors Grace Therapeutics Competitors Mersana Therapeutics Competitors BioXcel Therapeutics Competitors AlloVir Competitors Jasper Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LSB) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LakeShore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share LakeShore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
